myDNA provides direct-to-consumer DNA testing and analysis to support precision health. Its pharmacogenomics service analyzes how a person’s genes influence their response to medications to help clinicians optimize drug choice and dosing, reducing adverse effects. It also offers nutrigenomics insights to tailor nutrition, fitness, sleep, and vitamin plans, with reports sent to the patient’s healthcare provider. The company operates online test kits and pharmacy partnerships and expanded globally through a merger with Gene by Gene/FamilyTreeDNA, now owned by the DBG Group; its goal is to use genetic information to improve treatment effectiveness and overall wellbeing.
Company Size
11-50
Company Stage
Series A
Total Funding
$12.3M
Headquarters
Melbourne, Australia
Founded
2007
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?